
SGS-MDSAP
MDSAP (ISO 13485:2016)
Australia: Therapeutic Goods (Medical Devices) Regulations 2002, Schedule 3, Part 1-Full Quality Assurance System
Brazil: RDC ANVISA n. 665/2022- Good Manufacturing Practices; RDC ANVISA n. 551/2021–Field Actions; RDC ANVISA n. 67/2009- Vigilance
Canada: Medical Devices Regulations (SOR/98-282) Part 1-General
USA: 21 CFR Part 803-Medical Device Reporting; 21 CFR Part 806 -Reports of Corrections and Removals; 21 CFR Part 807 (Subparts A to D)-Establishment Registration and Device Listing, 21 CFR Part 820, Quality Management System Regulation
MDSAP (ISO 13485:2016)
Australia: Therapeutic Goods (Medical Devices) Regulations 2002, Schedule 3, Part 1-Full Quality Assurance System
Brazil: RDC ANVISA n. 665/2022- Good Manufacturing Practices; RDC ANVISA n. 551/2021–Field Actions; RDC ANVISA n. 67/2009- Vigilance
Canada: Medical Devices Regulations (SOR/98-282) Part 1-General
USA: 21 CFR Part 803-Medical Device Reporting; 21 CFR Part 806 -Reports of Corrections and Removals; 21 CFR Part 807 (Subparts A to D)-Establishment Registration and Device Listing, 21 CFR Part 820, Quality Management System Regulation

ISO 13485
ISO 13485:2016/EN ISO 13485:2016
Medical devices - Quality management systems - Requirements for regulatory purposes
ISO 13485:2016/EN ISO 13485:2016
Medical devices - Quality management systems - Requirements for regulatory purposes

EU Medical Device Notification
Medotex Biotech (HangZhou) Co., Ltd.
Our manufacturer has provided with all the appropriate declaration according the Directive 98/79/EC requirements including the EC Declaration of Conformity confirming that the in vitro diagnostic medical devices
Medotex Biotech (HangZhou) Co., Ltd.
Our manufacturer has provided with all the appropriate declaration according the Directive 98/79/EC requirements including the EC Declaration of Conformity confirming that the in vitro diagnostic medical devices


